308 related articles for article (PubMed ID: 23303926)
1. Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals.
Daberkow DP; Brown HD; Bunner KD; Kraniotis SA; Doellman MA; Ragozzino ME; Garris PA; Roitman MF
J Neurosci; 2013 Jan; 33(2):452-63. PubMed ID: 23303926
[TBL] [Abstract][Full Text] [Related]
2. High doses of amphetamine augment, rather than disrupt, exocytotic dopamine release in the dorsal and ventral striatum of the anesthetized rat.
Ramsson ES; Howard CD; Covey DP; Garris PA
J Neurochem; 2011 Dec; 119(6):1162-72. PubMed ID: 21806614
[TBL] [Abstract][Full Text] [Related]
3. Amphetamine elevates nucleus accumbens dopamine via an action potential-dependent mechanism that is modulated by endocannabinoids.
Covey DP; Bunner KD; Schuweiler DR; Cheer JF; Garris PA
Eur J Neurosci; 2016 Jun; 43(12):1661-73. PubMed ID: 27038339
[TBL] [Abstract][Full Text] [Related]
4. Amphetamine elicits opposing actions on readily releasable and reserve pools for dopamine.
Covey DP; Juliano SA; Garris PA
PLoS One; 2013; 8(5):e60763. PubMed ID: 23671560
[TBL] [Abstract][Full Text] [Related]
5. Amphetamine augments action potential-dependent dopaminergic signaling in the striatum in vivo.
Ramsson ES; Covey DP; Daberkow DP; Litherland MT; Juliano SA; Garris PA
J Neurochem; 2011 Jun; 117(6):937-48. PubMed ID: 21443523
[TBL] [Abstract][Full Text] [Related]
6. Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores.
Schmitz Y; Lee CJ; Schmauss C; Gonon F; Sulzer D
J Neurosci; 2001 Aug; 21(16):5916-24. PubMed ID: 11487614
[TBL] [Abstract][Full Text] [Related]
7. Biphasic mechanisms of amphetamine action at the dopamine terminal.
Siciliano CA; Calipari ES; Ferris MJ; Jones SR
J Neurosci; 2014 Apr; 34(16):5575-82. PubMed ID: 24741047
[TBL] [Abstract][Full Text] [Related]
8. Primary food reward and reward-predictive stimuli evoke different patterns of phasic dopamine signaling throughout the striatum.
Brown HD; McCutcheon JE; Cone JJ; Ragozzino ME; Roitman MF
Eur J Neurosci; 2011 Dec; 34(12):1997-2006. PubMed ID: 22122410
[TBL] [Abstract][Full Text] [Related]
9. Methamphetamine-induced neurotoxicity disrupts naturally occurring phasic dopamine signaling.
Howard CD; Daberkow DP; Ramsson ES; Keefe KA; Garris PA
Eur J Neurosci; 2013 Jul; 38(1):2078-88. PubMed ID: 23574406
[TBL] [Abstract][Full Text] [Related]
10. Methamphetamine-induced neurotoxicity disrupts pharmacologically evoked dopamine transients in the dorsomedial and dorsolateral striatum.
Robinson JD; Howard CD; Pastuzyn ED; Byers DL; Keefe KA; Garris PA
Neurotox Res; 2014 Aug; 26(2):152-67. PubMed ID: 24562969
[TBL] [Abstract][Full Text] [Related]
11. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):193-203. PubMed ID: 3007738
[TBL] [Abstract][Full Text] [Related]
12. Illicit dopamine transients: reconciling actions of abused drugs.
Covey DP; Roitman MF; Garris PA
Trends Neurosci; 2014 Apr; 37(4):200-10. PubMed ID: 24656971
[TBL] [Abstract][Full Text] [Related]
13. Repeated amphetamine exposure disrupts dopaminergic modulation of amygdala-prefrontal circuitry and cognitive/emotional functioning.
Tse MT; Cantor A; Floresco SB
J Neurosci; 2011 Aug; 31(31):11282-94. PubMed ID: 21813688
[TBL] [Abstract][Full Text] [Related]
14. Amphetamine-induced reverse transport of dopamine does not require cytosolic Ca
Støier JF; Konomi-Pilkati A; Apuschkin M; Herborg F; Gether U
J Biol Chem; 2023 Aug; 299(8):105063. PubMed ID: 37468107
[TBL] [Abstract][Full Text] [Related]
15. Direct and Systemic Administration of a CNS-Permeant Tamoxifen Analog Reduces Amphetamine-Induced Dopamine Release and Reinforcing Effects.
Carpenter C; Zestos AG; Altshuler R; Sorenson RJ; Guptaroy B; Showalter HD; Kennedy RT; Jutkiewicz E; Gnegy ME
Neuropsychopharmacology; 2017 Sep; 42(10):1940-1949. PubMed ID: 28492278
[TBL] [Abstract][Full Text] [Related]
16. Regionally distinct phasic dopamine release patterns in the striatum during reversal learning.
Klanker M; Fellinger L; Feenstra M; Willuhn I; Denys D
Neuroscience; 2017 Mar; 345():110-123. PubMed ID: 27185487
[TBL] [Abstract][Full Text] [Related]
17. Amphetamine augments vesicular dopamine release in the dorsal and ventral striatum through different mechanisms.
Avelar AJ; Juliano SA; Garris PA
J Neurochem; 2013 May; 125(3):373-85. PubMed ID: 23406303
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic response to graded dopamine concentration elicited by four amphetamine doses.
Ren J; Xu H; Choi JK; Jenkins BG; Chen YI
Synapse; 2009 Sep; 63(9):764-72. PubMed ID: 19484725
[TBL] [Abstract][Full Text] [Related]
19. Amphetamine activates Rho GTPase signaling to mediate dopamine transporter internalization and acute behavioral effects of amphetamine.
Wheeler DS; Underhill SM; Stolz DB; Murdoch GH; Thiels E; Romero G; Amara SG
Proc Natl Acad Sci U S A; 2015 Dec; 112(51):E7138-47. PubMed ID: 26553986
[TBL] [Abstract][Full Text] [Related]
20. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
